Skip to main content
GMED logo

GMED · Globus Medical Inc · Webcasts, Transcripts & Audio

Track GMED — free
$83.03 +1.77 (+2.18%) Q2 2026 earnings call transcript
Market Cap
$10.91B
Shares
134.26M
Volume · Oct 29 399.66K Avg daily vol (3M) 1.4M

Globus Medical Inc Webcasts

Earnings calls, investor updates, investor days and conferences for Globus Medical Inc (GMED), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Earnings call
FY26 · Q3
2026-11-05
Globus Medical Inc (GMED) Q3 2026 Earnings Call
Scheduled
Results not yet reported
Audio Transcript Slides 8-K10-Q
Conference
Investor event
2026-09-09
Globus Medical Inc (GMED) September 9, 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q2
2026-08-06
Globus Medical Inc (GMED) Q2 2026 Earnings Call Transcript
Positive tone Nevro integration and trial volumes Enabling tech capital model shift International spine expansion
Revenue
$789.61M
▲ 5.9% YoY
Diluted EPS
$1.10
▼ 26.2% YoY
Gross margin
69.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-07
Globus Medical Inc (GMED) Q1 2026 Earnings Call Transcript
Confident tone U.S. Spine growth and market share Enabling Technologies / Excelsius GPS International Spine
Revenue
$759.85M
▲ 27% YoY
Diluted EPS
$0.90
▲ 66.7% YoY
Gross margin
69.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-02-24
Globus Medical Inc (GMED) Q4 2025 Earnings Call Transcript
Confident tone Revenue growth and record Q4 Nevro integration U.S. Spine business momentum
Revenue
$826.42M*
▲ 25.7% YoY
Gross margin
68.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Conference
Investor event
2025-11-19
Globus Medical Inc (GMED) November 19, 2025 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY25 · Q3
2025-11-06
Globus Medical Inc (GMED) Q3 2025 Earnings Call Transcript
Confident tone Nevro integration and performance Trauma business Profitability and cash generation
Revenue
$769.05M
▲ 22.9% YoY
Diluted EPS
$0.88
▲ 131.6% YoY
Gross margin
67.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-07
Globus Medical Inc (GMED) Q2 2025 Earnings Call Transcript
Positive tone Nevro acquisition and integration Supply chain and operations NuVasive integration and in-sourcing
Revenue
$745.34M
▲ 18.4% YoY
Diluted EPS
$1.49
▲ 547.8% YoY
Gross margin
66.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-08
Globus Medical Inc (GMED) Q1 2025 Earnings Call Transcript
Positive tone Nevro acquisition Supply chain and integration disruptions Enabling technology and robotics
Revenue
$598.12M
▼ 1.4% YoY
Diluted EPS
$0.54
Gross margin
67.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-02-20
Globus Medical Inc (GMED) Q4 2024 Earnings Call Transcript
Confident tone NuVasive merger integration and synergies Revenue growth and financial records Enabling Technology and robotics
Revenue
$657.29M*
▲ 6.6% YoY
Gross margin
59.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-05
Globus Medical Inc (GMED) Q3 2024 Earnings Call Transcript
Confident tone Merger integration & synergies Enabling technology & robotics Product launches & innovation
Revenue
$625.71M
▲ 63.1% YoY
Diluted EPS
$0.38
▲ 3700% YoY
Gross margin
56.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-06
Globus Medical Inc (GMED) Q2 2024 Earnings Call Transcript
Confident tone Enabling Technology / Robotics Post-Merger Integration Trauma and NSO
Revenue
$629.69M
▲ 115.9% YoY
Diluted EPS
$0.23
▼ 59.6% YoY
Gross margin
58.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-07
Globus Medical Inc (GMED) Q1 2024 Earnings Call Transcript
Confident tone Merger Integration Revenue and Growth Margins and Profitability
Revenue
$606.67M
▲ 119.3% YoY
Diluted EPS
$-0.05
▼ 110.4% YoY
Gross margin
60.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-02-20
Globus Medical Inc (GMED) Q4 2023 Earnings Call Transcript
Confident tone NuVasive Merger Integration Financial Performance & Profitability Cash Flow & CapEx Discipline
Revenue
$616.53M*
▲ 124.6% YoY
Gross margin
56.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-07
Globus Medical Inc (GMED) Q3 2023 Earnings Call Transcript
Revenue
$383.64M
▲ 51% YoY
Diluted EPS
$0.01
▼ 97.9% YoY
Gross margin
64.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-03
Globus Medical Inc (GMED) Q2 2023 Earnings Call Transcript
Revenue
$291.62M
▲ 10.6% YoY
Diluted EPS
$0.57
▲ 7.5% YoY
Gross margin
73.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-04
Globus Medical Inc (GMED) Q1 2023 Earnings Call Transcript
Revenue
$276.69M
▲ 20% YoY
Diluted EPS
$0.48
▲ 29.7% YoY
Gross margin
74.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-02-21
Globus Medical Inc (GMED) Q4 2022 Earnings Call Transcript
Revenue
$274.50M*
▲ 9.8% YoY
Gross margin
74.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-08
Globus Medical Inc (GMED) Q3 2022 Earnings Call Transcript
Revenue
$254.15M
▲ 10.6% YoY
Diluted EPS
$0.47
▲ 4.4% YoY
Gross margin
74.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-04
Globus Medical Inc (GMED) Q2 2022 Earnings Call Transcript
Revenue
$263.65M
▲ 5% YoY
Diluted EPS
$0.53
▲ 32.5% YoY
Gross margin
74.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-05-10
Globus Medical Inc (GMED) Q1 2022 Earnings Call Transcript
Revenue
$230.55M
▲ 1.4% YoY
Diluted EPS
$0.37
▼ 15.9% YoY
Gross margin
74.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-02-17
Globus Medical Inc (GMED) Q4 2021 Earnings Call Transcript
Revenue
$250.02M*
▲ 7.1% YoY
Gross margin
75.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-04
Globus Medical Inc (GMED) Q3 2021 Earnings Call Transcript
Revenue
$229.72M
▲ 6.3% YoY
Diluted EPS
$0.45
▲ 2.3% YoY
Gross margin
74.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-04
Globus Medical Inc (GMED) Q2 2021 Earnings Call Transcript
Revenue
$251.02M
▲ 68.6% YoY
Diluted EPS
$0.40
Gross margin
74.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-04
Globus Medical Inc (GMED) Q1 2021 Earnings Call Transcript
Revenue
$227.34M
▲ 19.3% YoY
Diluted EPS
$0.44
▲ 76% YoY
Gross margin
75.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-02-17
Globus Medical Inc (GMED) Q4 2020 Earnings Call Transcript
Revenue
$233.44M
▲ 10.3% YoY
Diluted EPS
$0.52
▲ 18.2% YoY
Gross margin
73.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-10-28
Globus Medical Inc (GMED) Q3 2020 Earnings Call Transcript
Revenue
$216.10M
▲ 10.1% YoY
Diluted EPS
$0.44
▲ 15.8% YoY
Gross margin
73.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-08-05
Globus Medical Inc (GMED) Q2 2020 Earnings Call Transcript
Revenue
$148.92M
▼ 23.4% YoY
Diluted EPS
$-0.21
▼ 155.3% YoY
Gross margin
66.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-05-07
Globus Medical Inc (GMED) Q1 2020 Earnings Call Transcript
Revenue
$190.58M
▲ 4.2% YoY
Diluted EPS
$0.25
▼ 24.2% YoY
Gross margin
74.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–29 of 29 webcasts
Key facts CIK 1237831 CUSIP 379577208 13F (30d) 170 filings 163 filers Visit website Investor relations